Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

cyclosporine metabolite M17

Known as: CsA M17, cyclosporin metabolite m17, hydroxycyclosporine 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BackgroundPlasmodium falciparum M1 family aminopeptidase is currently considered as a promising target for anti-malarial… Expand
  • table 1
  • figure 1
  • figure 3
  • figure 4
2015
2015
The Plasmodium falciparum PfA-M1 and PfA-M17 metalloaminopeptidases are validated drug targets for the discovery of antimalarial… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2015
2015
New anti‐malarial treatments are desperately required to face the spread of drug resistant parasites. Inhibition of… Expand
2013
2013
The M1 alanyl aminopeptidase from Plasmodium falciparum has been shown to be an essential hemoglobinase enzyme, catalyzing the… Expand
2011
2011
The aim of this study was to investigate whether lactic acid bacteria (LAB), isolated from cheese, were able to degrade terpenes… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
2009
2009
A study was carried out at Sokoine University of Agriculture to characterize the local rice varieties grown in Morogoro Region… Expand
  • table 1
  • table 3
  • table 2
  • table 4
2009
2009
We present 3D hydrodynamical simulations of the superbubble M17, also known as the Omega Nebula, carried out with the adaptive… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2008
2008
Das Projekt sollte gemaess seiner ersten Definition die Fragen der Dauerhaftigkeit der bituminoesen Belaege und die Problematik… Expand
1998
1998
The responsiveness of human gingival fibroblast populations to cyclosporin A (CsA) and its principal metabolite… Expand
1994
1994
The anti-tumour antibody-dependent cell-mediated cytotoxicity (ADCC) capacity of the conventional antibody m17-1A was compared… Expand
  • table I
  • figure 1
  • table 11
  • figure 5